The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma-Reference-Cited by-同舟云学术

The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma

Published:2024-02-01 Issue:6 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Wu Muzhou,Hanly Ailish,Gibson Frederick,Fisher Robert,Rogers Samantha,Park Kihyun,Zuger Angelina,Kuang Kevin,Kalin Jay H.^ORCID,Nocco Sarah,Cole Matthew,Xiao Amy,Agus Filisia,Labadorf Adam^ORCID,Beck Samuel^ORCID,Collard Marianne,Cole Philip A.,Alani Rhoda M.

Funder

Karin Grunebaum Cancer Foundation

National Institutes of Health

Melanoma Research Alliance

Publisher

American Society for Clinical Investigation

Link

https://www.jci.org/articles/view/171063/files/pdf

Reference61 articles.

1. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

2. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

3. In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States

4. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state

5. Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone deacetylase complexes: Structure, regulation and function;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors;2024-08-19

3. Targeting the Epigenome Reduces Keloid Fibroblast Cell Proliferation, Migration, and Invasion;Journal of Investigative Dermatology;2024-07

4. Pan-cancer transcriptional atlas of minimal residual disease links DUSP1 to chemotherapy persistence;Experimental Hematology & Oncology;2024-04-16